CFR Eyes Local Funds

CFR Eyes Local Funds

Chile Bonds

Chile’s CFR Pharmaceuticals is scheduled to price today a domestic bond transaction of UF1m ($45m), according to a prospectus. The pharmaceutical specialist is able choose between a 5-year bullet tranche with a 3.5% coupon and a 21-year tranche with a 10-year grace period and 4.0% coupon, according to people following the sale. Proceeds will be used for general corporate purposes, with 75% heard to be destined for working capital and about 25% for organic growth. IMTrust and Santander are managi

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial